Windtree Therapeutics Inc (WINT)
4.57
+0.51
(+12.56%)
USD |
NASDAQ |
May 15, 14:36
Windtree Therapeutics Cash from Investing (Quarterly): 0.00 for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | -0.015M |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.20M |
| March 31, 2022 | -0.003M |
| December 31, 2021 | -0.173M |
| September 30, 2021 | -0.103M |
| June 30, 2021 | -0.003M |
| March 31, 2021 | 0.00 |
| December 31, 2020 | -0.264M |
| September 30, 2020 | -0.015M |
| June 30, 2020 | -0.012M |
| March 31, 2020 | |
| December 31, 2019 | -0.062M |
| September 30, 2019 | 2.597M |
| June 30, 2019 | 10.84M |
| March 31, 2019 | 0.425M |
| December 31, 2018 | -13.74M |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.009M |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2017 | 0.00 |
| June 30, 2017 | -0.004M |
| March 31, 2017 | -0.02M |
| December 31, 2016 | -0.088M |
| September 30, 2016 | -0.017M |
| June 30, 2016 | -0.012M |
| March 31, 2016 | -0.137M |
| December 31, 2015 | 0.06M |
| September 30, 2015 | -0.005M |
| June 30, 2015 | 0.205M |
| March 31, 2015 | -0.448M |
| December 31, 2014 | -0.101M |
| September 30, 2014 | 0.204M |
| June 30, 2014 | -0.386M |
| March 31, 2014 | -0.497M |
| December 31, 2013 | -0.404M |
| September 30, 2013 | -0.084M |
| June 30, 2013 | 0.00 |
| March 31, 2013 | -0.12M |
| December 31, 2012 | -0.043M |
| September 30, 2012 | -0.075M |
| June 30, 2012 | -0.38M |
| March 31, 2012 | -0.138M |
| December 31, 2011 | -0.018M |
| September 30, 2011 | -0.062M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-0.264M
Minimum
Dec 2020
10.84M
Maximum
Jun 2019
0.7213M
Average
-0.0015M
Median
Cash from Investing (Quarterly) Benchmarks
| Lexicon Pharmaceuticals Inc | -110.22M |
| AIM ImmunoTech Inc | -0.214M |
| Perspective Therapeutics Inc | -0.089M |
| Protalix BioTherapeutics Inc | -0.606M |
| Armata Pharmaceuticals Inc | -0.25M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.567M |
| Cash from Financing (Quarterly) | 0.521M |
| Free Cash Flow | -13.45M |
| Free Cash Flow Per Share (Quarterly) | -11.86 |
| Free Cash Flow Yield | -1.37K% |